CDC25C and neoplasm: It has been reported that increased expression of ILP-2 prevents the inhibitory activity of CHK2 on CDC25C (113), thereby promoting the transition of the tumor cell cycle from G2 to M phase and supporting tumor cell proliferation (114, 115).